Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

COVID-19 In Vitro Diagnostic Medical Device - detail

FAMEX SARS-CoV-2 RAPID ANTIBODY TEST

Manufactured by fago medikal san. tic. Ltd. ÅŸti., Turkey - http://famextestkit.com/ 

Device identification number
2175
CE Marking
Yes
HSC common list (RAT)
×No
Format
Near POC / POC
Physical Support
Cassette, Fingertip
Target type
Antibody, IgG, IgM
Specimen
Whole blood, Whole blood with anti-coagulants
Cross-reactivity (pathogens tested)
Coronaviruses (HCoV), SARS-CoV
Lineages detected
A.23.1, AT.1, B.1.1.7 (Alpha), B.1.351 (Beta), B.1.427 (Epsilon), B.1.429 (Epsilon), B.1.525 (Eta), B.1.526 (Iota), B.1.526.1, B.1.526.2, B.1.616, B.1.617.1 (Kappa), B.1.617.2 (Delta), B.1.617.3, B.1.621 (Mu), C.36, C.37 (Lambda), P.1 (Gamma), P.2 (Zeta), P.3 (Theta)
Commercial Status
Commercialised
Last Update
2022-08-24 09:08:01 CET
Comments
sars-cov 2 antikörper rapid test
Assay Type
Immuno-Antibody
Reader Required
No
Method
Immunoassay
Measurement
Qualitative
Time
10 minutes
LOD
100 AU
Calibration
Evaluated
Analytical Sensitivity
85 % IgM
Analysis of cross reactivity
Evaluated
False positives
10 AU
False negatives
8 AU
Precision
Evaluated
Accuracy
98.6 % IgG
Accuracy
92.8 % IgM
Reproducibility
Evaluated
Robustness
Evaluated
Clinical Sensitivity
100 % IgG
Clinical Specificity
98 % IgG
Clinical Specificity
96 % IgM
Type of antigen
Nucleoprotein

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements